Financing channel feed – Endpoints News

Financing channel feed

Arch joins Celgene, China investors bankrolling a pioneering New York biotech startup focused on a new approach to metastasis

7 years ago

Here come the 2019 unicorns: Alector, Gossamer set to launch IPOs donning $1B-plus market caps

7 years ago

Peter Diamandis' right hand man Sergey Young wants to reverse aging via his $100M Longevity Vision Fund

7 years ago

Medicxi bankrolls the launch of a pair of biotech twins focused on orexins for narcolepsy and more

7 years ago

With US government shutdown over, Gossamer reverts to traditional IPO plan

7 years ago

Polaris’ Amir Nashat pulls together a $60M launch round to back the birth of a new biotech building a drug development platform from scratch

7 years ago

Gates and Chinese private equity group cheer on Lyndra's PhII plans with $55M raise

7 years ago

Unfazed by Brexit blues, UK biotech trade group celebrates boisterous year of venture dollars with record £1.1B total

7 years ago

By the numbers for 2018: The top 100 venture players in biotech — and who's been paying the piper in cancer R&D?

7 years ago

Scoop: GSK’s venture team at SR One in talks to spin off from its big pharma founder, now under new R&D management

7 years ago

Shutdown thrusts Gossamer Bio onto a rarely used path for fixed-price IPO

7 years ago

KKR backs monster $300M raise to build up a new-model biotech — designed by Neil Kumar and MIT’s Andrew Lo

7 years ago

Novo infuses cash into 4 biotechs, adding to their arsenal for the superbugs battle to come

7 years ago

Cambridge spinout grabs $23M round to launch a new campaign to tackle protein misfolding

7 years ago

Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt

7 years ago

Live to 150? Jim Mellon and the crew at Juvenescence just raised $46M more to give it a try

7 years ago

Harvard prof David Sinclair backs anti-aging upstart Life Bio, which just raised $50M for research

7 years ago

Kaleido, Cirius brace the IPO market seeking a combined $186M — despite barriers at shutdown-mode SEC

7 years ago

Betting on allosteric mutations driving cancer, Black Diamond raises $85M in fresh round

7 years ago

How to build a biotech unicorn: Get the star team in place, attract deep-pocket VCs, paint a big picture and raise up to $1B

7 years ago

Ramping up in-house drug development, API maker BrightGene bags $80M round led by Sequoia China

7 years ago

Championed by AbbVie, immuno-neurology player Alector maps $150M IPO

7 years ago

Prepping a cross-Pacific move, OrbiMed-backed Apollomics bags $100M Series B for I/O combos

7 years ago

Bill Gates backs Schrödinger's $85M venture raise for its standout computational drug discovery platform

7 years ago

First page Previous page 116 117 118119120 121 122 Next page Last page